Literature DB >> 27468083

Pembrolizumab-Induced Demyelinating Polyradiculoneuropathy.

Marie-Florence de Maleissye1, Guillaume Nicolas1, Philippe Saiag1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27468083     DOI： 10.1056/NEJMc1515584

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  20 in total

1.  Guillain-Barré syndrome in patients treated with immune checkpoint inhibitors.

Authors:  Qianqian Fan; Yang Hu; Xiang Wang; Bin Zhao
Journal:  J Neurol       Date:  2021-01-21       Impact factor: 4.849

Review 2.  Neurological Complications of Therapeutic Monoclonal Antibodies: Trends from Oncology to Rheumatology.

Authors:  Chandler Gill; Stasia Rouse; Ryan D Jacobson
Journal:  Curr Neurol Neurosci Rep       Date:  2017-08-17       Impact factor: 5.081

Review 3.  Chemotherapy-induced peripheral neuropathy: A current review.

Authors:  Nathan P Staff; Anna Grisold; Wolfgang Grisold; Anthony J Windebank
Journal:  Ann Neurol       Date:  2017-06-05       Impact factor: 10.422

Review 4.  Neurologic Immune-Related Adverse Events Associated with Immune Checkpoint Inhibition.

Authors:  Peter Chei-Way Pan; Aya Haggiagi
Journal:  Curr Oncol Rep       Date:  2019-11-27       Impact factor: 5.075

5.  Siponimod enriches regulatory T and B lymphocytes in secondary progressive multiple sclerosis.

Authors:  Qi Wu; Elizabeth A Mills; Qin Wang; Catherine A Dowling; Caitlyn Fisher; Britany Kirch; Steven K Lundy; David A Fox; Yang Mao-Draayer
Journal:  JCI Insight       Date:  2020-02-13

6.  Neurological Complications Associated With Anti-Programmed Death 1 (PD-1) Antibodies.

Authors:  Justin C Kao; Bing Liao; Svetomir N Markovic; Christopher J Klein; Elie Naddaf; Nathan P Staff; Teerin Liewluck; Julie E Hammack; Paola Sandroni; Heidi Finnes; Michelle L Mauermann
Journal:  JAMA Neurol       Date:  2017-10-01       Impact factor: 18.302

7.  Case Report: Encephalitis, with Brainstem Involvement, Following Checkpoint Inhibitor Therapy in Metastatic Melanoma.

Authors:  Simon Bossart; Selina Thurneysen; Elisabeth Rushing; Karl Frontzek; Henning Leske; Daniela Mihic-Probst; Hannes W Nagel; Johanna Mangana; Simone M Goldinger; Reinhard Dummer
Journal:  Oncologist       Date:  2017-05-30

Review 8.  Neurological Adverse Events Associated with Immune Checkpoint Inhibitors: Diagnosis and Management.

Authors:  Christophoros Astaras; Rita de Micheli; Bianca Moura; Thomas Hundsberger; Andreas F Hottinger
Journal:  Curr Neurol Neurosci Rep       Date:  2018-02-01       Impact factor: 5.081

Review 9.  Neuromuscular Complications of Programmed Cell Death-1 (PD-1) Inhibitors.

Authors:  Justin C Kao; Adipong Brickshawana; Teerin Liewluck
Journal:  Curr Neurol Neurosci Rep       Date:  2018-08-04       Impact factor: 5.081

10.  Neurological complications of new chemotherapy agents.

Authors:  Alicia M Zukas; David Schiff
Journal:  Neuro Oncol       Date:  2018-01-10       Impact factor: 12.300
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.